\r\n\t \r\n\t \r","showSummary":null,"url":"/pharmacy/kaloroma-retail-clinics-represent-big-business-ivd-products-poc-testing","date":"2016-09-28T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":{"id":59096,"url":"https://assets1.drugstorenews.com/styles/secondary_articles_short/s3/teaser_image_386348.jpg?itok=MUowDMJN","width":767,"height":575,"alt":null},"topics":[{"name":"News","url":"/news"},{"name":"RETAIL NEWS","url":"/retail-news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"Retail Clinics","url":"/retail-clinics"}],"attachedFiles":[]},{"title":"Convenient Care Association chief to helm Woods Resources","id":27122,"bundle":"article","summary":null,"showSummary":null,"url":"/pharmacy/convenient-care-association-chief-helm-woods-resources","date":"2016-09-27T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":{"id":59082,"url":"https://assets1.drugstorenews.com/styles/secondary_articles_short/s3/teaser_image_386332.jpg?itok=pPbmrz2i","width":767,"height":575,"alt":null},"topics":[{"name":"News","url":"/news"},{"name":"RETAIL NEWS","url":"/retail-news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"Retail Clinics","url":"/retail-clinics"}],"attachedFiles":[]},{"title":"FDA approves Janssen’s Invokamet XR","id":27176,"bundle":"article","summary":"
\r\n\tSILVER SPRING, Md. — The Food and Drug Administration has approved Janssen Pharmaceuticals’ Invokamet XR, a once-daily, extended-release combination therapy of Invokana (canagliflozin) and metformin, the company announced Wednesday. The drug is indicated as a first-line treatment to improve blood glucose control in adults with Type 2 diabetes alongside diet and exercise.
\r\n
\r\n\t
\r\n
\r","showSummary":null,"url":"/pharmacy/fda-approves-janssens-invokamet-xr","date":"2016-09-21T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":{"id":59029,"url":"https://assets1.drugstorenews.com/styles/secondary_articles_short/s3/teaser_image_386276.jpg?itok=aUuiokp4","width":767,"height":575,"alt":null},"topics":[{"name":"News","url":"/news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"Branded","url":"/branded"},{"name":"Retail Clinics","url":"/retail-clinics"},{"name":"Diabetes","url":"/diabetes"}],"attachedFiles":[]},{"title":"Pfizer launches Moodivator app for patients with depression","id":27235,"bundle":"article","summary":"
\r\n\tNEW YORK — Pfizer has launched a new app, Moodivator, aimed at helping to motivate and encourage patients with depression. The app is designed to help patients track their mood, set goals and establish routines as a complement to their treatment for depression, which can include talk therapy, medication and other approaches.
NEW YORK — A recent survey from CityMD Urgent Care is finding that a lot of people aren’t planning on getting flu shots, and among millennials, slightly more than half of them don’t plan on getting vaccinated against the flu this year.
ATLANTA — In its Morbidity and Mortality Weekly Report, the Centers for Disease Control and Prevention break down a survey about influenza vaccination among healthcare professionals, noting that employer vaccine requirements or on-site vaccination can help achieve better coverage.
ST. PAUL, Minn. — Pharmacy benefit manager Prime Therapeutics recently analyzed pharmacy claims for short- and long-acting opioids, finding a decrease in short-acting opioid claims and an increase in long-acting opioid claims. The review of 15 million commercially insured members found an overall 3.9% decrease in opioid claims from 2014 to 2015.
NEW YORK - With the number of U.S. clinics located within retail locations exceeding 2,000, they have become an important target for in vitro diagnostic products and point-of-care testing, Kalorama Information reported Wednesday.
SILVER SPRING, Md. — The Food and Drug Administration has approved Janssen Pharmaceuticals’ Invokamet XR, a once-daily, extended-release combination therapy of Invokana (canagliflozin) and metformin, the company announced Wednesday. The drug is indicated as a first-line treatment to improve blood glucose control in adults with Type 2 diabetes alongside diet and exercise.
NEW YORK — Pfizer has launched a new app, Moodivator, aimed at helping to motivate and encourage patients with depression. The app is designed to help patients track their mood, set goals and establish routines as a complement to their treatment for depression, which can include talk therapy, medication and other approaches.